CDK12 inhibitors and their uses
US11596631B2 · kind B2 · utility
1Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2017 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Apr 21, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2892
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to inhibitors of CDK12 (cyclin-dependent kinase 12), and there use in the treatment or prevention of a disorder in a subject caused by the generation of repeat expansion transcripts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.